Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection - A pilot study

Journal of Viral Hepatitis

Volumn 8, Issue 4, 2001, Pages 287-292

  Bruchfeld, A ^a   Stahle L ^a   Andersson, J ^a   Schvarcz, R ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anaemia; Dialysis; Erythropoeitin; Hepatitis C; Interferon; Plasma concentration; Ribavirin

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; DIALYSIS; DOSE RESPONSE; DRUG BLOOD LEVEL; FATIGUE; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MYALGIA; PATIENT COMPLIANCE; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; BIOPSY; DRUG THERAPY, COMBINATION; ERYTHROPOIESIS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER; MALE; MIDDLE AGED; PILOT PROJECTS; POLYMERASE CHAIN REACTION; RENAL DIALYSIS; RIBAVIRIN; RNA, VIRAL;

EID: 0034923464     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2001.00300.x     Document Type: Article

References (20)

1. Clinical outcomes after transfusion-associated hepatitis C
2. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
3. A twelve year natural history of hepatitis C virus infection in hemodialyzed patients
4. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years
5. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients
6. Impact of hepatitis B and C virus on kidney transplantation outcome
7. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience
8. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks treatment of chronic infection with hepatitis C virus
9. Interferon alfa-2b alone or in combination ribavirin as initial treatment for chronic hepatitis C
10. High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alfa therapy
11. Interferon-alpha in chronic hepatitis C infection in dialysis patients
12. Treatment of chronic hepatitis C: Another therapeutic option
13. Hemodialysis clearance of intravenously administered ribavirin
14. Treatment of chronic hepatitis C in special groups
15. Determination of ribavirin in serum using highly selective solid-phase extraction and high performance liquid chromatography
16. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection
17. Chronic hepatitis. An update on terminology and reporting
18. Ribavirin and interferon alfa-2b in chronic hepatitis C assessment of possible pharmacokinetic and pharmacodynamic interactions
19. Nephrology Forum. The anemia of chronic renal failure: Patophysiology and the effects of recombinant erythropoeitin
20. High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients